成人神经胃肠病患者中回避/限制性食物摄入障碍的患病率与特征
该回顾性研究纳入2016年连续转诊至三级中心的410例神经胃肠病检查成人患者,采用DSM-5标准评估回避/限制性食物摄入障碍(ARFID)。有进食或体重相关主诉、消化不良/恶心/呕吐、腹痛或下消化道诊断的患者ARFID症状风险显著增高。
要点
- 神经胃肠病检查成人中6.3%符合ARFID全部标准,17.3%有临床显著的回避/限制进食但信息不足。
- 92.8%的ARFID症状患者因害怕胃肠道症状而回避或限制进食。
- 有进食或体重相关主诉、消化不良/恶心/呕吐、腹痛或下消化道诊断者ARFID症状风险增高。
核心结论
- 神经胃肠病患者中ARFID症状多与害怕胃肠道症状相关,建议对接受神经胃肠病或动力检查者评估ARFID症状,尤其考虑饮食干预时。
研究设计与样本
- 由4名盲法编码者依据DSM-5标准评估ARFID,诊断一致性κ=0.66。
主要发现
- 97例有ARFID症状的患者中,90例(92.8%)因害怕胃肠道症状而回避或限制进食。
- 有进食或体重相关主诉者ARFID症状的OR为5.09(95%CI 2.54-10.21)。
- 有消化不良、恶心或呕吐者ARFID症状的OR为3.59(95%CI 2.04-6.32)。
- 有腹痛者ARFID症状的OR为4.72(95%CI 1.87-11.81),有下消化道诊断者OR为2.40(95%CI 1.34-4.32)。
临床怎么用
- 对接受神经胃肠病或动力检查的患者应评估ARFID症状,尤其在考虑饮食干预时。
- 对以害怕胃肠道症状为由回避或限制进食者,需警惕ARFID。
- 对有进食或体重相关主诉、消化不良/恶心/呕吐、腹痛或下消化道诊断者,应提高对ARFID症状的筛查意识。
局限性
- 回顾性病历审查设计。
- 部分患者信息不足以确诊ARFID。
- 单中心三级转诊人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Avoidant/restrictive food intake disorder (ARFID) is a feeding and eating disorder that is characterized by avoidant or restrictive eating not primarily motivated by body shape or weight concerns. We aimed to determine the frequency of ARFID symptoms and study its characteristics and associated gastrointestinal symptoms. METHODS: We conducted a retrospective review of charts from 410 consecutive referrals (ages, 18-90 y; 73.0% female) to a tertiary care center for neurogastroenterology examination, from January through December 2016. Blinded coders (n = 4) applied Diagnostic and Statistical Manual of Mental Disorders, 5th edition, criteria for ARFID, with substantial diagnostic agreement (κ = 0.66). RESULTS: Twenty-six cases (6.3%) met the full criteria for ARFID and 71 cases (17.3%) had clinically significant avoidant or restrictive eating behaviors with insufficient information for a definitive diagnosis of ARFID. Of patients with ARFID symptoms (n = 97), 90 patients (92.8%) cited fear of gastrointestinal symptoms as motivation for their avoidant or restrictive eating. A series of binary logistic regressions showed that the likelihood of having ARFID symptoms increased significantly in patients with eating- or weight-related complaints (odds ratio [OR], 5.09; 95% CI, 2.54-10.21); with dyspepsia, nausea, or vomiting (OR, 3.59; 95% CI, 2.04-6.32); with abdominal pain (OR, 4.72; 95% CI, 1.87-11.81); or with lower GI diagnoses (OR, 2.40; 95% CI, 1.34-4.32). CONCLUSIONS: In a retrospective study of patients undergoing neurogastroenterology examinations, we found ARFID symptoms to be related most frequently to fear of gastrointestinal symptoms. Patients undergoing neurogastroenterology or motility examinations should be evaluated for symptoms of ARFID, particularly when providers consider dietary interventions.
引用
- Murray HB, Bailey AP, Keshishian AC, et al. Prevalence and Characteristics of Avoidant/Restrictive Food Intake Disorder in Adult Neurogastroenterology Patients. Clin Gastroenterol Hepatol. 2019. PMID: 31669056. doi:10.1016/j.cgh.2019.10.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。